GENSCRIPT BIO (1548.HK)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jiange Meng | Executive Chairman | 3.65M | -- | 1968 |
| Ms. Weihui Shao | CEO & COO | 4.34M | -- | 1981 |
| Ms. Ye Wang M.S. | Co-Founder, President & Executive Director | 5.43M | -- | 1968 |
| Dr. Luquan Wang | Co-Founder & Non-Executive Director | -- | -- | 1969 |
| Dr. Fangliang Zhang EMBA, Ph.D. | Co-Founder & Executive Director | 4.74M | -- | 1965 |
| Dr. Li Zhu Ph.D. | Chief Strategy Officer & Executive Director | 2.19M | -- | 1950 |
| Mr. Shiniu Wei | Chief Financial Officer | -- | -- | 1980 |
| Dr. Kening Li J.D. | General Counsel & Chief Compliance Officer | -- | -- | -- |
| Dr. Raymond Miller | Head of Corporate Communications | -- | -- | -- |
| Ms. Aylin Kosova Bilgin | Chief Marketing Officer for GenScript Life Science Group | -- | -- | -- |
GENSCRIPT BIO
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5,568
Description
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment and consumables, such as molecular diagnostics tools and genome editing materials for biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and the food industry. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People's Republic of China.
Corporate Governance
Upcoming Events
March 11, 2025 at 10:59 AM UTC
GENSCRIPT BIO Earnings Date
Recent Events
June 5, 2017 at 12:00 AM UTC
Ex-Dividend Date